• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFECELL STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 20, FIRM; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFECELL STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 20, FIRM; MESH, SURGICAL Back to Search Results
Catalog Number 2020002
Device Problem Insufficient Information (3190)
Patient Problems Hernia (2240); Post Operative Wound Infection (2446)
Event Date 12/19/2013
Event Type  Injury  
Manufacturer Narrative
Invalid product information.If additional information is received a follow up will be submitted.
 
Event Description
Follow up with legal on (b)(6) 2021.No updated information received strattice was confirmed usage.Reporting in an abundance of caution.On (b)(6) 2021 abbvie legal received a complaint from a legal patient representative.Documentation was submitted for two pieces of strattice used on a patient within 1 year of each other for a hernia repair.The product did not have valid lot numbers and limited information on the failure.We reported in an abundance of caution for the most current case under, 1000306051-2021-00043, but because it could not be confirmed why strattice failed in the first procedure and used again 1 years later.This mdr is for the first use of strattice in 2013.Allergan usa, inc., allergan, inc.And lifecell were served with these new strattice complaints on (b)(6) 2021.
 
Manufacturer Narrative
Review of the processing history records for lot s11222 is as follows: pouch integrity inspection showed no significant bulges, holes, tears, wrinkles or physical defects.The lot was aseptically processed, terminally sterilized, and met qc release criteria.There were no processing deviations or nonconformances related to the nature of this complaint.As of 07/11/22, of the 194 devices released to finished goods for lot s11222, 192 have been distributed, with 12 reported as implanted.
 
Event Description
Additional information was reported to abbvie on june 22, 20022 reporting the lot number associated with this complaint, lot s11222-65 was implanted on (b)(6) 2013.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 20 X 20, FIRM
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
LIFECELL
one millennium way
branchburg NJ 08876
Manufacturer (Section G)
BRANCHBURG
one millennium way
branchburg NJ 08876
Manufacturer Contact
christopher belle
one millennium way
branchburg, NJ 08876
9089471470
MDR Report Key12175927
MDR Text Key263485288
Report Number1000306051-2021-00048
Device Sequence Number1
Product Code FTM
UDI-Device Identifier00818410010140
UDI-Public00818410010140
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K070560
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 07/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/30/2015
Device Catalogue Number2020002
Device Lot NumberS11222
Was Device Available for Evaluation? No
Date Manufacturer Received06/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-